POLAND

Press release - Women must have full control of their sexual and reproductive health and rights

Retrieved on: 
Thursday, April 18, 2024
Human sexuality, Health, Education, SRHR, Woman, Background, Health care, Poverty, Parliament, Commission, Council, Fundamental rights, Curriculum, Reproductive rights, Abortion, Birth control

MEPs condemn the backsliding on women’s rights and all attempts to restrict or remove existing protections for sexual and reproductive health and rights (SRHR) and gender equality taking place globally, including in the EU member states.

Key Points: 
  • MEPs condemn the backsliding on women’s rights and all attempts to restrict or remove existing protections for sexual and reproductive health and rights (SRHR) and gender equality taking place globally, including in the EU member states.
  • They call on the Commission to ensure that organisations working against gender equality and women’s rights, including reproductive rights, do not receive EU funding.
  • Healthcare, including sexual and reproductive health, falls under national powers.
  • Changing the EU Charter of Fundamental Rights to include abortion would require unanimous agreement from all member states.

EQS-News: IMMOFINANZ sells office properties in Vienna

Retrieved on: 
Wednesday, April 10, 2024
Environment, VIVO, ATX, Sale

IMMOFINANZ is taking another step in optimising its portfolio by selling two office properties in Vienna.

Key Points: 
  • IMMOFINANZ is taking another step in optimising its portfolio by selling two office properties in Vienna.
  • The properties in the 20th district of Vienna have been successfully sold to an Austrian real estate investor.
  • The two office properties in Dresdnerstraße in Vienna’s 20th district offer modern and flexible offices with approximately 13,000 sqm of usable space in the northern business district of Vienna.
  • The core business covers the management and development of properties, whereby IMMOFINANZ relies on its established real estate brands – STOP SHOP (retail), VIVO!

EQS-News: Third acquisition in 2024: Mutares has signed an agreement to acquire Eltel Networks Energetyka S.A. and Eltel Networks Engineering S.A. from Eltel AB

Retrieved on: 
Wednesday, April 10, 2024
EUR, Holding company, Supervisory board, Frankfurt Stock Exchange, Acquisition, SDAX, Goods, Regulated market, MUX, HQ, Porcelain

Third acquisition in 2024: Mutares has signed an agreement to acquire Eltel Networks Energetyka S.A. and Eltel Networks Engineering S.A. from Eltel AB

Key Points: 
  • Third acquisition in 2024: Mutares has signed an agreement to acquire Eltel Networks Energetyka S.A. and Eltel Networks Engineering S.A. from Eltel AB
    The issuer is solely responsible for the content of this announcement.
  • Third acquisition in 2024: Mutares has signed an agreement to acquire Eltel Networks Energetyka S.A. and Eltel Networks Engineering S.A. from Eltel AB
    Munich, April 10, 2024 – Mutares SE & Co. KGaA (ISIN: DE000A2NB650) has signed an agreement to acquire Eltel Networks Energetyka S.A. and Eltel Networks Engineering S.A. from Eltel AB.
  • In business since 1961 and 1949 respectively, Eltel Networks Energetyka S.A. and Eltel Networks Engineering S.A. are among the leading providers of electrical power engineering services in Poland with revenues of approx.
  • Robin Laik, CEO of Mutares, comments: "With the acquisition of Eltel Networks Energetyka and Eltel Networks Engineering, we are signing our first transaction in Poland strengthening our Goods & Services segment in the field of electrical power engineering & construction services.

EQS-News: CPI PROPERTY GROUP publishes financial results for 2023

Retrieved on: 
Wednesday, April 10, 2024
WAULT, EUR, CPI, Growth, Capital expenditure, ICR, Environment, GSG, Hotel, Webcast, CEE, NAV, EPRA, Investment, LTV, FFO

CPI PROPERTY GROUP (hereinafter “CPIPG”, the “Company” or together with its subsidiaries the “Group”), a leading European landlord, hereby publishes audited financial results for the financial year ended 31 December 2023.

Key Points: 
  • CPI PROPERTY GROUP (hereinafter “CPIPG”, the “Company” or together with its subsidiaries the “Group”), a leading European landlord, hereby publishes audited financial results for the financial year ended 31 December 2023.
  • “CPIPG’s results in 2023 demonstrate the resilient and high-yielding nature of real estate in the CEE region,” said David Greenbaum, CEO.
  • The Group raised over €2.5 billion of secured and unsecured external financing in 2023, including €1.2 billion of fresh cash.
  • CPIPG will host a webcast in relation to its financial results for 2023.

EQS-News: IMMOFINANZ 2023 with strong operating performance

Retrieved on: 
Wednesday, April 10, 2024
EUR, Growth, Supervisory board, AG, VIVO, ATX, CPI Property Group, S IMMO, Bank statement, Investment, LTV, FFO, NTA, Cryptocurrency

IMMOFINANZ Group generated strong growth in rental income and operating results during the 2023 financial year.

Key Points: 
  • IMMOFINANZ Group generated strong growth in rental income and operating results during the 2023 financial year.
  • “We achieved above-average operating results in 2023 in spite of the difficult macroeconomic environment.
  • This performance underscores the success of our strategy to invest in higher-yielding properties to strengthen our earning power“, explained Radka Doehring, Member of the Executive Board of IMMOFINANZ.
  • Revaluations (including development projects and property sales) totalled EUR -376.8 million in 2023, compared with EUR -105.7 million in the previous year.

EQS-News: Mainz Biomed Reports Full Year 2023 Financial Results

Retrieved on: 
Wednesday, April 10, 2024
Gene expression, Colorectal cancer, Partnership, Patient, Biomarker, Gold, Pivotal, Messenger, Oncology, Science, PMA, CRC, EOL, Marketing, FDA, Physician, Quest Diagnostics, Vaccine

ColoAlert® Revenue Increased 69% Year Over Year; Net Loss in Line with Previous Year; Cash Balance at Year End of $7.1 Million

Key Points: 
  • ColoAlert® Revenue Increased 69% Year Over Year; Net Loss in Line with Previous Year; Cash Balance at Year End of $7.1 Million
    BERKELEY, US – MAINZ, Germany – April 9, 2024 — Mainz Biomed N.V. (NASDAQ:MYNZ) (“Mainz Biomed” or the “Company”), a leader in molecular genetics diagnostic solutions for early cancer detection, announced today financial results for the fiscal year ended December 31, 2023.
  • “This past fiscal year represented an important period of progress for the Company highlighted by reporting results from our groundbreaking ColoFuture and eAArly DETECT studies which demonstrated extraordinary statistical significance for colorectal cancer (CRC) detection and advanced adenomas, a type of pre-cancerous polyp which are considered precursors to colorectal cancer” commented Guido Baechler, Chief Executive Officer of Mainz Biomed.
  • Final preparations for Pivotal FDA PMA clinical trial (ReconAAsense) evaluating gold standard self-administered CRC test - on track to commence patient enrollment in 2024.
  • Established commercial operations in major markets including Spain, Poland, Romania, Portugal, Israel, and the UK.

EQS-News: Photon Energy Group Secures Polish Capacity Market Contracts for 316 MW, Locking in Revenues of EUR 13 Million for 2025

Retrieved on: 
Wednesday, April 10, 2024
Photon, EUR, DSR, Photon energy, FSX, Growth, Q1, Electricity, Acquisition, Q4, PLN, HVAC, Q3, Costochondritis, Demand-side, Renewable energy

Photon Energy Group Secures Polish Capacity Market Contracts for 316 MW, Locking in Revenues of EUR 13 Million for 2025

Key Points: 
  • Photon Energy Group Secures Polish Capacity Market Contracts for 316 MW, Locking in Revenues of EUR 13 Million for 2025
    The issuer is solely responsible for the content of this announcement.
  • Photon Energy Group Secures Polish Capacity Market Contracts for 316 MW, Locking in Revenues of EUR 13 Million for 2025
    As a result of additional auctions for 2025, the Company concluded contracts for 316 MW (out of which 315 MW is DSR capacity) in addition to the previously contracted 10 MW for the same year, ensuring PLN 56.1 million (EUR 13 million) in revenues for 2025.
  • With the previously contracted capacity of 10 MW for 2025, the Company’s total capacity obligation of 316.088 MW will ensure PLN 56.1 million (EUR 13 million) in Capacity Market revenues for 2025.
  • Photon Energy participated and secured 316 MW in capacity, with 315 MW designated for DSR (Demand Side Response) units.

Electrical vehicle charging station operator ZES and electrip join Hubject's global intercharge roaming network

Retrieved on: 
Wednesday, April 10, 2024
EV, CPO, Partnership, ZES, Carbon, Rail transport

ZES and electrip; joint ventures of Zorlu Enerji & WrenHouse established under Electrip Global Ltd and Hubject, the world's largest charging network provider, have signed a partnership to enhance e-roaming solutions.

Key Points: 
  • ZES and electrip; joint ventures of Zorlu Enerji & WrenHouse established under Electrip Global Ltd and Hubject, the world's largest charging network provider, have signed a partnership to enhance e-roaming solutions.
  • Amsterdam - ZES, as one of Turkey's leading charge point operators (CPO); and electrip as the fresh CPO in European market; have announced a business partnership with Hubject, the world's the largest charging network provider for electric vehicles.
  • İ. Sinan Ak, CEO of Electrip Global Ltd, commented on the partnership: “We launched ZES in 2018 to support electric vehicle owners in Turkey with our intra and intercity charging stations, and recently introduced “electrip” in Europe to speed up the electric vehicle revolution.
  • Hubject CEO Christian Hahn added: "We're happy to welcome ZES and electrip into the inter-charge CPO network.

EQS-News: Dermapharm Holding SE fulfils all expectations despite multiple macroeconomic challenges

Retrieved on: 
Wednesday, April 10, 2024
Annual, Tax, Aggression, COVID-19, Euromed, Supervision, Acquisition, Management, Annual report, Depreciation, PPA, Parallel, Lithium

Grünwald, 28 March 2024 – Dermapharm Holding SE ("Dermapharm"), a rapidly growing manufacturer of branded pharmaceuticals, today published its full Annual Report 2023.

Key Points: 
  • Grünwald, 28 March 2024 – Dermapharm Holding SE ("Dermapharm"), a rapidly growing manufacturer of branded pharmaceuticals, today published its full Annual Report 2023.
  • Despite a difficult macroeconomic environment, Dermapharm succeeded in maintaining its growth trajectory and hitting the upper end of the guidance range in 2023.
  • "In addition to the end of the boom phase associated with vaccine production, 2023 was also shaped by various other macroeconomic and geopolitical challenges.
  • The Annual General Meeting of Dermapharm Holding SE will take place on 27 June 2024.

EQS-News: Westwing ended 2023 with continued profitable growth in Q4 and started well into 2024. Topline outlook remains cautious.

Retrieved on: 
Wednesday, April 10, 2024
EUR, Software as a service, Science Based Targets initiative, Growth, Breuninger, FY, Shop, Science, Collection, Marketing, Annual general meeting, Investment, Working capital, GMV, Targets

Westwing ended 2023 with continued profitable growth in Q4 and started well into 2024.

Key Points: 
  • Westwing ended 2023 with continued profitable growth in Q4 and started well into 2024.
  • Westwing ended 2023 with continued profitable growth in Q4 and started well into 2024.
  • Westwing also delivered profitability in the upper half of the updated (increased) guidance, with EUR 18 million Adjusted EBITDA in FY 2023.
  • Due to the ongoing challenging market environment as well as topline risks in Italy and Spain, Revenue outlook for 2024 is still cautious.